Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kou-Yan-Ning
- Development stage
- Unknown
- Lead developer
- Conba Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Topical
01
Overview
Kou-Yan-Ning is a Traditional Chinese Medicine (TCM) formulation used for the treatment of oral inflammatory conditions, including oral mucositis, stomatitis, and gingivitis. It is typically composed of extracts from *Scrophularia ningpoensis*, *Ophiopogon japonicus*, *Lonicera japonica*, *Glycyrrhiza uralensis*, and *Paeonia lactiflora*. The drug is designed to clear heat, nourish yin, and reduce swelling and pain in the oral cavity. It is widely used in China to manage drug-induced oral mucosal lesions, particularly those resulting from chemotherapy or targeted antitumor therapies. The formulation is available in various forms, such as granules and solutions, and is manufactured by companies including Zhejiang Conba Pharmaceutical.
- Brand names
- Kou-Yan-Ning
- Other names
- KouyanningKouyanning GranulesKouyanning Solution
Beyond the preview
Go deeper on Kou-Yan-Ning.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kou-Yan-Ning.